Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Choose New Jersey

Choose New Jersey CEO Michele Brown: ‘Access to Lab Space, Funding and Partners Help Biotech Companies Grow in Garden State’

Michele Brown (Photo: NJBIZ/Aaron Houston)

Trenton, NJ, August 1, 2017Choose New Jersey, Inc. led a delegation representing more than 20 New Jersey organizations — including top life sciences companies, universities, trade associations, state officials — as it showcased New Jersey’s assets and resources for biotechnology companies at BIO International 2017, which was June 19-22 in San Diego, California. 

Prior to the BIO event, Choose New Jersey President and Chief Executive Officer Michele Brown in June wrote:

When Hurel Corporation outgrew its incubator space at the Commercialization Center for Innovative Technologies (CCIT) in North Brunswick, New Jersey in 2016, it marked an important milestone for the biotechnology company. Continue reading

Choose New Jersey Showcases State’s Assets, Resources at BIO International 2017 This Week

Princeton, NJ, June 22, 2017 — A delegation representing more than 20 New Jersey organizations, including top life sciences companies, universities, trade associations, State government and Choose New Jersey, Inc. is showcasing New Jersey’s assets and resources for biotechnology companies at the New Jersey Pavilion (Booth #1737) at BIO International 2017, June 19-22 (2017) in San Diego, California.

During the world’s largest biotechnology conference, members of the New Jersey delegation are holding business meetings with executives representing companies in North America, Europe and Asia interested in learning more about the benefits of a New Jersey location. Continue reading

Choose New Jersey Helps Evotec Celebrate Opening of U.S. Headquarters, Facility Expansion in Princeton

Princeton, NJ, June 14, 2017 — Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809), a global drug discovery alliance and development partnership company headquartered in Hamburg, Germany, celebrated the opening of its U.S. headquarters and expanded facility in Princeton, New Jersey.

Werner Lanthaler, Chief Executive Officer of Evotec AG and Ryan Brady, the company’s Executive Vice President Business Development and Head of U.S. Operations were joined by Michele Brown, President and CEO of Choose New Jersey, Inc. and Debbie Hart, President and CEO of BioNJ to cut the ribbon for the new U.S. headquarters. Continue reading

HINJ to Serve as Lead Sponsor of Choose New Jersey’s Annual Reception at BIO International on June 19 in San Diego

New Brunswick, NJ, May 19, 2016 — The HealthCare Institute of New Jersey (HINJ) will serve, once again, as the lead sponsor of Choose New Jersey’s annual reception at BIO International Convention on Monday, June 19 from 5:00 to 7:00 p.m. at Top of the Hyatt at the Grand Hyatt San Diego.

Choose New Jersey will showcase top life sciences companies, universities, trade associations, the State government at its New Jersey Pavilion (Booth #1737) at BIO International 2017, which will be held from June 19 to 22 at the San Diego Convention Center. Continue reading

NJ EDA to Fill Market Need for Seed-Stage Capital Through NJ CoVest Fund; Aims to Help New Innovative Tech and Life Science Companies Thrive

Trenton, NJ, April 18, 2017 — The New Jersey Economic Development Authority (EDA) on April 13 announced the creation of the NJ CoVest Fund, which will provide growth capital to early-stage technology and life sciences companies, driving up to $9 million in investment.

The NJ CoVest Fund will fill a market need in New Jersey, ensuring the availability of capital at a company’s critical stage between product development and commercial operation expansion, where limited funds are currently available and a funding gap exists. Continue reading

NJBIZ Editorial: NJ Tech Council’s Jim Barrood on ‘Recruiting New Business Is a Job for Everyone’

jim-barrood-linkedin

Jim Barrood

New Brunswick, NJ, November 7, 2016In a November 6 editorial, NJBIZ writes:

Some may call it a publicity stunt — and, since we are writing about it here, it would be a successful one — but we feel the open letter from the New Jersey Tech Council to the New York tech community encouraging its members to cross the river is more than that.

To us, it’s another effort by forces in our state to help business and industry grow and flourish. And there can never be enough efforts in that direction.

The letter, penned by Jim Barrood, the Tech Council’s CEO and president, came in response to the latest battles new-era companies Airbnb and Uber are having with New York City and its seemingly anti-business Mayor Bill de Blasio. Continue reading

Choose New Jersey Unveils New Data-Driven Website; Spotlights Why Businesses Should Select the Garden State

Choose New Jersey logoPrinceton, NJ, September 8, 2016 — Anjalee Khemlani reports on NJBIZ that Choose New Jersey has launched a new website, giving it a more attractive look and making it easy to read across all devices — mobile and computers.

The new “data driven website” offers diverse content, a home page to spotlight the reasons to choose New Jersey for business, and gives businesses interested in the state all the information necessary to make a decision.

The home page has a top bar menu, followed by images of Princeton University and the Statue of Liberty. Continue reading

BF Business Facilities: 60 Seconds with Choose New Jersey CEO Michele Brown

Michele Brown

Michele Brown

Tinton, NJ, August 27, 2016 — Michele Brown, President and CEO, Choose New Jersey, Inc., sat down with the staff of  BF Business Facilities to discuss incubators, innovation zones, STEM education, incentives and the Garden State in a post-Panamax world.

BF: NJ has established five incubator centers in the state for tech start-ups. Are each of them targeting a different growth sector?

MB: New Jersey is committed to nurturing start-up companies in our key industries and has an extensive network of incubators, accelerators and co-working spaces to support them.

The Commercialization Center for Innovative Technologies (CCIT) is one of the most significant incubation facilities in the U.S. dedicated to life sciences and biotechnology. Located in the heart of New Jersey’s Continue reading

Scientific American Worldview Calls New Jersey ‘An Unyielding Driver of 21st Century Biotech Innovation’

New Jersey pin horizontalTrenton, NJ, June 14, 2016 ― Scientific American Worldview, the annual custom edition on global biotechnology innovation, debuted last week at the BIO International Convention in San Francisco, touting New Jersey’s “bumper-to-bumper innovation, first-rate workforce, world-class institutions and business friendly resources.”

This report comes on the heels of The Value of Bioscience Innovation in Growing Jobs and Improving Quality of Life 2016, released last Tuesday by TEConomy and BIO, which cites New Jersey as topping the list of states with a high degree of specialization in four of five industry sub-sectors. Continue reading

New Jersey Showcases Its Life Sciences’ Leadership at BIO International 2016

BIO International Convention LOGOPrinceton, NJ, June 8, 2016 — New Jersey is showcasing more than 20 organizations, including top companies, universities, trade associations, State government and Choose New Jersey, Inc. at the New Jersey Pavilion (Booth #6544, North Exhibition Hall) at Bio International 2016, the world’s largest biotechnology conference.

From June 7-9, the New Jersey delegation will meet with European, Canadian and Australian business executives from life science-based organizations interested in learning what makes the State a perfect place to start or relocate their bio-related firm.

“New Jersey is an undisputed leader in life sciences,” says Michele Brown, President and CEO of Choose New Jersey, Inc.  “Our great State consistently ranks among the nation’s top states in every critical category, including talent, industry support and innovation. BIO 2016 gives us the strategic opportunity to present New Jersey’s assets to an international community of biopharmaceutical executives.” Continue reading